Table 1

Patient characteristics at the intervention ite

CharacteristicsPre (n=517)Post (n=446)P
Age, mean (SD)64.8 (16.8)63.2 (15.7)0.149
Female315 (60.9)213 (47.8)<0.001
Race0.326
 White385 (74.6)322 (72.2)
 African–American122 (23.6)110 (24.7)
 Other9 (1.7)14 (3.1)
Non-Hispanic502 (97.3)434 (97.3)0.983
Body mass index, mean (SD)31.0 (11.2)31.0 (10.2)0.974
Charlson Comorbidity Index, mean (SD)3.05 (2.4)4.18 (2.8)<0.001
Comorbidities
 AIDS/HIV2 (0.4)10 (2.2)0.010
 Cerebrovascular disease102 (19.7)83 (18.6)0.660
 Coagulopathy7 (1.4)14 (3.1)0.059
 Dementia56 (10.8)41 (9.2)0.399
 Diabetes, complicated and uncomplicated224 (43.3)185 (41.5)0.563
 Hyperlipidaemia108 (20.9)108 (24.2)0.217
 Hypertension393 (76.0)318 (71.3)0.097
 Mild liver disease30 (5.8)42 (9.4)0.033
 Moderate/severe liver disease10 (1.9)16 (3.6)0.114
 Moderate/severe chronic kidney disease135 (26.1)177 (39.7)<0.001
 Peptic ulcer disease10 (1.9)19 (4.3)0.035
 Peripheral vascular disease59 (11.4)55 (12.3)0.660
 History of chronic obstructive pulmonary disease182 (35.2)196 (44.0)0.006
 History of congestive heart failure179 (34.6)177 (39.7)0.105
 History of rheumatoid arthritis23 (4.5)29 (6.5)0.160
Length of stay in days, median (IQR)11 (7–18)12 (8–20)0.015
Payer0.024
 Medicare320 (62.9)235 (53.2)
 Medicaid81 (15.9)91 (20.6)
 Other103 (20.2)112 (25.3)
 No insurance5 (1.0)4 (0.90)